Stay updated with breaking news from Procaps Group. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Procaps Group S.A (NASDAQ:PROC – Get Rating) and FSD Pharma (NASDAQ:HUGE – Get Rating) are both small-cap medical companies, but which is the better investment? We will compare the two companies based on the strength of their earnings, profitability, analyst recommendations, valuation, institutional ownership, risk and dividends. Profitability This table compares Procaps Group S.A and […]
Dublin, March 24, 2022 (GLOBE NEWSWIRE) -- The "Vegetarian Softgel Capsules Market by Material, Application and Distribution Channel: Global Opportunity...
Procaps Group S.A (NASDAQ:PROC – Get Rating)’s share price gapped down before the market opened on Monday . The stock had previously closed at $8.97, but opened at $8.32. Procaps Group S.A shares last traded at $8.21, with a volume of 300 shares. Several equities research analysts have commented on PROC shares. Zacks Investment Research […]
Procaps Group S.A (NASDAQ:PROC – Get Rating) saw a significant growth in short interest during the month of February. As of February 28th, there was short interest totalling 727,800 shares, a growth of 38.2% from the February 13th total of 526,800 shares. Currently, 2.8% of the company’s shares are sold short. Based on an average […]
/PRNewswire/ -- /PRNewswire/ -- Allied Market Research published a report, titled, "Vegetarian Softgel Capsules Market by Material (Starch, Cellulose, and...